Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Fuji
Moodys
US Department of Justice
Fish and Richardson
McKinsey
Harvard Business School
Citi
Deloitte

Generated: February 25, 2018

DrugPatentWatch Database Preview

Deferiprone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for deferiprone and what is the scope of deferiprone patent protection?

Deferiprone
is the generic ingredient in one branded drug marketed by Apopharma Inc and is included in two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Deferiprone has forty-two patent family members in twenty-four countries.

There are four drug master file entries for deferiprone. One supplier is listed for this compound.
Pharmacology for deferiprone
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity

US Patents and Regulatory Information for deferiprone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for deferiprone

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Healthtrust
Colorcon
AstraZeneca
Federal Trade Commission
Johnson and Johnson
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot